These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3243 related articles for article (PubMed ID: 10995877)

  • 61. Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease.
    Safranek J; Pesta M; Holubec L; Kulda V; Dreslerova J; Vrzalova J; Topolcan O; Pesek M; Finek J; Treska V
    Anticancer Res; 2009 Jul; 29(7):2513-7. PubMed ID: 19596921
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Regulated expression of matrix metalloproteinases and TIMP in nephrogenesis.
    Tanney DC; Feng L; Pollock AS; Lovett DH
    Dev Dyn; 1998 Sep; 213(1):121-9. PubMed ID: 9733107
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line.
    Lu KV; Jong KA; Rajasekaran AK; Cloughesy TF; Mischel PS
    Lab Invest; 2004 Jan; 84(1):8-20. PubMed ID: 14631378
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
    Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
    Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Analysis of matrix metalloproteinases and related tissue inhibitors in cystic fluids of ovarian tumors.
    Furuya M
    Hokkaido Igaku Zasshi; 1999 Mar; 74(2):145-55. PubMed ID: 10386163
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Matrix metalloproteinase-9 expression correlates with prognosis and involved in ovarian cancer cell invasion.
    Hu X; Li D; Zhang W; Zhou J; Tang B; Li L
    Arch Gynecol Obstet; 2012 Dec; 286(6):1537-43. PubMed ID: 22832979
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation in primary human ovarian epithelial carcinoma cells.
    Fishman DA; Bafetti LM; Stack MS
    Invasion Metastasis; 1996; 16(3):150-9. PubMed ID: 9186550
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Immunohistochemical detection of membrane-type-1-matrix metalloproteinase in colorectal carcinoma.
    Kikuchi R; Noguchi T; Takeno S; Kubo N; Uchida Y
    Br J Cancer; 2000 Jul; 83(2):215-8. PubMed ID: 10901373
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immunohistochemical study of matrix metalloproteinases-2 and -9, macrophage inflammatory protein-2 and tissue inhibitors of matrix metalloproteinases-1 and -2 in normal, purulonecrotic and fungal infected equine corneas.
    Boveland SD; Moore PA; Mysore J; Krunkosky TM; Dietrich UM; Jarrett C; Paige Carmichael K
    Vet Ophthalmol; 2010 Mar; 13(2):81-90. PubMed ID: 20447025
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging.
    Baker EA; Bergin FG; Leaper DJ
    Br J Surg; 2000 Sep; 87(9):1215-21. PubMed ID: 10971431
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases and vascular endothelial growth factor in canine mast cell tumours.
    Giantin M; Aresu L; Benali S; Aricò A; Morello EM; Martano M; Vascellari M; Castagnaro M; Lopparelli RM; Zancanella V; Granato A; Mutinelli F; Dacasto M
    J Comp Pathol; 2012 Nov; 147(4):419-29. PubMed ID: 22520817
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Expression of matrix metalloproteinases and their inhibitors in retinoblastoma.
    Adithi M; Nalini V; Kandalam M; Krishnakumar S
    J Pediatr Hematol Oncol; 2007 Jun; 29(6):399-405. PubMed ID: 17551402
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1-matrix metalloproteinase in esophageal squamous cell carcinomas.
    Ohashi K; Nemoto T; Nakamura K; Nemori R
    Cancer; 2000 May; 88(10):2201-9. PubMed ID: 10820340
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer].
    Fu XR; Zhang C; Chen CY; Zhang L; Wang LX; Wang BH; Liu XY; Zhang MZ
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):369-73. PubMed ID: 22883459
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human urothelial carcinomas.
    Kitagawa Y; Kunimi K; Ito H; Sato H; Uchibayashi T; Okada Y; Seiki M; Namiki M
    J Urol; 1998 Oct; 160(4):1540-5. PubMed ID: 9751409
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Expression of metalloproteinases and their tissue inhibitors in gingiva affected by hereditary gingival fibromatosis: analysis of three cases within a family.
    Gonçalves Lda R; Oliveira GA; Borojevic R; Otazu IB; Feres-Filho EJ
    J Periodontal Res; 2009 Dec; 44(6):714-7. PubMed ID: 19453853
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Progesterone differentially regulates the membrane-type matrix metalloproteinase-1 (MT1 -MMP) compartment of proMMP-2 activation in MG-63 cells.
    Luo XH; Liao EY
    Horm Metab Res; 2001 Jul; 33(7):383-8. PubMed ID: 11507673
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis.
    Sugiura Y; Shimada H; Seeger RC; Laug WE; DeClerck YA
    Cancer Res; 1998 May; 58(10):2209-16. PubMed ID: 9605768
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Localization of MT1-MMP, TIMP-1, TIMP-2, and TIMP-3 messenger RNA in normal, hyperplastic, and neoplastic endometrium. Enhanced expression by endometrial adenocarcinomas is associated with low differentiation.
    Määttä M; Soini Y; Liakka A; Autio-Harmainen H
    Am J Clin Pathol; 2000 Sep; 114(3):402-11. PubMed ID: 10989641
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Clinical significance of matrix metalloproteinase-2 expression in patients with epithelial ovarian tumor].
    Wu X; Li H; Song J
    Zhonghua Fu Chan Ke Za Zhi; 2001 Oct; 36(10):621-4. PubMed ID: 16134528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 163.